blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2474530

EP2474530 - INDOLE DERIVATIVE AND PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.07.2015
Database last updated on 13.07.2024
Most recent event   Tooltip12.10.2018Lapse of the patent in a contracting state
New state(s): AL		published on 14.11.2018  [2018/46]
Applicant(s)For all designated states
Kissei Pharmaceutical Co., Ltd.
19-48, Yoshino Matsumoto-shi
Nagano 399-8710 / JP
[2012/23]
Inventor(s)01 / KONDO, Tatsuhiro
c/o Central Research Laboratories
Kissei Pharmaceutical Co. Ltd.
4365-1 Hotaka-Kashiwabara
Azumino-shi Nagano 399-8304 / JP
02 / KONDO, Atsushi
c/o Central Research Laboratories
Kissei Pharmaceutical Co. Ltd.
4365-1 Hotaka-Kashiwabara
Azumino-shi Nagano 399-8304 / JP
03 / TATANI, Kazuya
c/o Central Research Laboratories
Kissei Pharmaceutical Co. Ltd.
4365-1 Hotaka-Kashiwabara
Azumino-shi Nagano 399-8304 / JP
04 / KAWAMURA, Naohiro
c/o Central Research Laboratories
Kissei Pharmaceutical Co. Ltd.
4365-1 Hotaka-Kashiwabara
Azumino-shi Nagano 399-8304 / JP
 [2012/23]
Representative(s)Boult Wade Tennant LLP
Salisbury Square House
8 Salisbury Square
London EC4Y 8AP / GB
[N/P]
Former [2014/02]Boult Wade Tennant
Verulam Gardens
70 Gray's Inn Road
London WC1X 8BT / GB
Former [2012/23]Hayes, Adrian Chetwynd, et al
Boult Wade Tennant Verulam Gardens 70 Gray's Inn Road
London WC1X 8BT / GB
Application number, filing date10804369.626.07.2010
WO2010JP62532
Priority number, dateJP2009017385227.07.2009         Original published format: JP 2009173852
JP2009025284604.11.2009         Original published format: JP 2009252846
[2012/23]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2011013623
Date:03.02.2011
Language:JA
[2011/05]
Type: A1 Application with search report 
No.:EP2474530
Date:11.07.2012
Language:EN
[2012/28]
Type: B1 Patent specification 
No.:EP2474530
Date:03.09.2014
Language:EN
[2014/36]
Search report(s)International search report - published on:JP03.02.2011
(Supplementary) European search report - dispatched on:EP29.11.2012
ClassificationIPC:C07D209/18, C07D401/04, C07D401/06, C07D401/14, C07D405/04, C07D405/06, C07D405/14, C07D409/04, C07D409/06, C07D409/14, C07D413/14, C07D417/06, C07D417/14, A61K31/404, A61K31/422, A61K31/427, A61K31/4439, A61P13/02, A61P43/00
[2013/01]
CPC:
A61K31/404 (EP,US); C07D401/06 (EP,CN,KR,US); A61K31/422 (EP,US);
A61K31/427 (EP,US); A61K31/4439 (EP,US); A61K31/454 (KR);
A61P13/00 (EP); A61P13/02 (EP); A61P43/00 (EP);
C07D209/18 (EP,CN,KR,US); C07D401/04 (EP,US); C07D401/14 (EP,US);
C07D405/04 (EP,US); C07D405/06 (EP,US); C07D405/14 (EP,CN,US);
C07D409/04 (EP,US); C07D409/06 (EP,US); C07D409/14 (EP,CN,US);
C07D413/14 (EP,US); C07D417/06 (EP,US); C07D417/14 (EP,CN,US) (-)
Former IPC [2012/23]C07D209/18, A61K31/404, A61K31/422, A61K31/427, A61K31/4439, A61P13/02, A61P43/00, C07D401/04, C07D401/06, C07D401/14, C07D405/04, C07D405/06, C07D405/14, C07D409/04, C07D409/06, C07D409/14, C07D413/14, C07D417/06, C07D417/14
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2012/23]
Extension statesBA24.02.2012
ME24.02.2012
RS24.02.2012
TitleGerman:INDOLDERIVAT UND PHARMAZEUTISCH AKZEPTABLES SALZ DARAUS[2012/23]
English:INDOLE DERIVATIVE AND PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF[2012/23]
French:DÉRIVÉ D'INDOLE ET SEL PHARMACOLOGIQUEMENT ACCEPTABLE DE CELUI-CI[2012/23]
Entry into regional phase24.02.2012Translation filed 
24.02.2012National basic fee paid 
24.02.2012Search fee paid 
24.02.2012Designation fee(s) paid 
24.02.2012Examination fee paid 
Examination procedure24.02.2012Examination requested  [2012/23]
12.06.2013Amendment by applicant (claims and/or description)
14.11.2013Communication of intention to grant the patent
13.03.2014Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
26.03.2014Communication of intention to grant the patent
24.07.2014Fee for grant paid
24.07.2014Fee for publishing/printing paid
24.07.2014Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  14.11.2013
Opposition(s)04.06.2015No opposition filed within time limit [2015/33]
Fees paidRenewal fee
24.07.2012Renewal fee patent year 03
24.07.2013Renewal fee patent year 04
24.07.2014Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU26.07.2010
AL03.09.2014
AT03.09.2014
BE03.09.2014
BG03.09.2014
CY03.09.2014
CZ03.09.2014
DK03.09.2014
EE03.09.2014
ES03.09.2014
FI03.09.2014
HR03.09.2014
IT03.09.2014
LT03.09.2014
LV03.09.2014
MC03.09.2014
MK03.09.2014
MT03.09.2014
NL03.09.2014
PL03.09.2014
RO03.09.2014
SE03.09.2014
SI03.09.2014
SK03.09.2014
SM03.09.2014
TR03.09.2014
NO03.12.2014
GR04.12.2014
IS03.01.2015
PT05.01.2015
[2018/46]
Former [2018/30]HU26.07.2010
AT03.09.2014
BE03.09.2014
BG03.09.2014
CY03.09.2014
CZ03.09.2014
DK03.09.2014
EE03.09.2014
ES03.09.2014
FI03.09.2014
HR03.09.2014
IT03.09.2014
LT03.09.2014
LV03.09.2014
MC03.09.2014
MK03.09.2014
MT03.09.2014
NL03.09.2014
PL03.09.2014
RO03.09.2014
SE03.09.2014
SI03.09.2014
SK03.09.2014
SM03.09.2014
TR03.09.2014
NO03.12.2014
GR04.12.2014
IS03.01.2015
PT05.01.2015
Former [2017/38]HU26.07.2010
AT03.09.2014
BE03.09.2014
BG03.09.2014
CY03.09.2014
CZ03.09.2014
DK03.09.2014
EE03.09.2014
ES03.09.2014
FI03.09.2014
HR03.09.2014
IT03.09.2014
LT03.09.2014
LV03.09.2014
MC03.09.2014
MT03.09.2014
NL03.09.2014
PL03.09.2014
RO03.09.2014
SE03.09.2014
SI03.09.2014
SK03.09.2014
SM03.09.2014
TR03.09.2014
NO03.12.2014
GR04.12.2014
IS03.01.2015
PT05.01.2015
Former [2017/21]AT03.09.2014
BE03.09.2014
CY03.09.2014
CZ03.09.2014
DK03.09.2014
EE03.09.2014
ES03.09.2014
FI03.09.2014
HR03.09.2014
IT03.09.2014
LT03.09.2014
LV03.09.2014
MC03.09.2014
MT03.09.2014
NL03.09.2014
PL03.09.2014
RO03.09.2014
SE03.09.2014
SI03.09.2014
SK03.09.2014
NO03.12.2014
GR04.12.2014
IS03.01.2015
PT05.01.2015
Former [2016/33]AT03.09.2014
BE03.09.2014
CY03.09.2014
CZ03.09.2014
DK03.09.2014
EE03.09.2014
ES03.09.2014
FI03.09.2014
HR03.09.2014
IT03.09.2014
LT03.09.2014
LV03.09.2014
MC03.09.2014
NL03.09.2014
PL03.09.2014
RO03.09.2014
SE03.09.2014
SI03.09.2014
SK03.09.2014
NO03.12.2014
GR04.12.2014
IS03.01.2015
PT05.01.2015
Former [2016/13]AT03.09.2014
CY03.09.2014
CZ03.09.2014
DK03.09.2014
EE03.09.2014
ES03.09.2014
FI03.09.2014
HR03.09.2014
IT03.09.2014
LT03.09.2014
LV03.09.2014
MC03.09.2014
NL03.09.2014
PL03.09.2014
RO03.09.2014
SE03.09.2014
SI03.09.2014
SK03.09.2014
NO03.12.2014
GR04.12.2014
IS03.01.2015
PT05.01.2015
Former [2015/50]AT03.09.2014
CY03.09.2014
CZ03.09.2014
DK03.09.2014
EE03.09.2014
ES03.09.2014
FI03.09.2014
HR03.09.2014
IT03.09.2014
LT03.09.2014
LV03.09.2014
NL03.09.2014
PL03.09.2014
RO03.09.2014
SE03.09.2014
SI03.09.2014
SK03.09.2014
NO03.12.2014
GR04.12.2014
IS03.01.2015
PT05.01.2015
Former [2015/37]AT03.09.2014
CY03.09.2014
CZ03.09.2014
DK03.09.2014
EE03.09.2014
ES03.09.2014
FI03.09.2014
HR03.09.2014
IT03.09.2014
LT03.09.2014
LV03.09.2014
NL03.09.2014
PL03.09.2014
RO03.09.2014
SE03.09.2014
SK03.09.2014
NO03.12.2014
GR04.12.2014
IS03.01.2015
PT05.01.2015
Former [2015/35]AT03.09.2014
CY03.09.2014
CZ03.09.2014
DK03.09.2014
EE03.09.2014
ES03.09.2014
FI03.09.2014
HR03.09.2014
LT03.09.2014
LV03.09.2014
NL03.09.2014
PL03.09.2014
RO03.09.2014
SE03.09.2014
SK03.09.2014
NO03.12.2014
GR04.12.2014
IS03.01.2015
PT05.01.2015
Former [2015/24]AT03.09.2014
CY03.09.2014
CZ03.09.2014
EE03.09.2014
ES03.09.2014
FI03.09.2014
HR03.09.2014
LT03.09.2014
LV03.09.2014
NL03.09.2014
PL03.09.2014
RO03.09.2014
SE03.09.2014
SK03.09.2014
NO03.12.2014
GR04.12.2014
IS03.01.2015
PT05.01.2015
Former [2015/23]AT03.09.2014
CY03.09.2014
CZ03.09.2014
EE03.09.2014
ES03.09.2014
FI03.09.2014
HR03.09.2014
LT03.09.2014
LV03.09.2014
NL03.09.2014
RO03.09.2014
SE03.09.2014
SK03.09.2014
NO03.12.2014
GR04.12.2014
IS03.01.2015
PT05.01.2015
Former [2015/22]AT03.09.2014
CY03.09.2014
ES03.09.2014
FI03.09.2014
HR03.09.2014
LT03.09.2014
LV03.09.2014
NL03.09.2014
RO03.09.2014
SE03.09.2014
NO03.12.2014
GR04.12.2014
PT05.01.2015
Former [2015/16]AT03.09.2014
CY03.09.2014
ES03.09.2014
FI03.09.2014
HR03.09.2014
LT03.09.2014
LV03.09.2014
NL03.09.2014
SE03.09.2014
NO03.12.2014
GR04.12.2014
Former [2015/12]AT03.09.2014
CY03.09.2014
ES03.09.2014
FI03.09.2014
HR03.09.2014
LT03.09.2014
LV03.09.2014
SE03.09.2014
NO03.12.2014
GR04.12.2014
Former [2015/11]CY03.09.2014
ES03.09.2014
FI03.09.2014
LT03.09.2014
SE03.09.2014
NO03.12.2014
GR04.12.2014
Former [2015/10]ES03.09.2014
FI03.09.2014
LT03.09.2014
SE03.09.2014
NO03.12.2014
Former [2015/09]FI03.09.2014
LT03.09.2014
SE03.09.2014
Former [2015/08]LT03.09.2014
Documents cited:Search[A]WO9851667  (CHUGAI PHARMACEUTICAL CO LTD [JP], et al) [A] 1-17* abstract *;
 [AP]WO2009156462  (NOVARTIS AG [CH], et al) [AP] 1-17 * example 35; claims 1,16 *
International search[A]US4510158  (BAILEY DENIS M [US]);
 [A]  - HALL, A. ET AL., "Discovery of a novel indole series of EP1 receptor antagonists by scaffold hopping", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, (2008), vol. 18, no. 8, pages 2684 - 2690, XP022606372

DOI:   http://dx.doi.org/10.1016/j.bmcl.2008.03.018
by applicantUS4510158
 JP2008214224
    - NARIHITO SEKI, FOLIA PHARMACOLOGIA JAPONICA, (2007), vol. 129, pages 368 - 373
    - XIAOJUN WANG ET AL., BIOMEDICAL RESEARCH, (2008), vol. 29, pages 105 - 111
    - MASAHITO KAWATANI, PAIN RESEARCH, (2004), vol. 19, pages 185 - 190
    - MASANOBU MAEGAWA, THE JOURNAL OF THE JAPAN NEUROGENIC BLADDER SOCIETY, (2008), vol. 19, page 169
    - ADRIAN HALL ET AL., BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, (2008), pages 2684 - 2690
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.